AEON Biopharma, Inc. - Common Stock (AEON)

15 filings reported holding AEON - AEON Biopharma, Inc. - Common Stock as of Q1 2025.
AEON Biopharma, Inc. - Common Stock (AEON) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,526,776 shares of 11,898,571 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include Dauntless Investment Group, LLC (1,025,000 shares), SABBY MANAGEMENT, LLC (449,687 shares), Blue Owl Capital Holdings LP (42,353 shares), BlackRock, Inc. (3,671 shares), UBS Group AG (2,957 shares), BANK OF AMERICA CORP /DE/ (2,319 shares), DUPONT CAPITAL MANAGEMENT CORP (170 shares), MORGAN STANLEY (150 shares), SBI Securities Co., Ltd. (106 shares), and Steward Partners Investment Advisory, LLC (100 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.